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A systematic study of the fragmentation pattern of phosphopeptides in an electrospray (ESI)
ion trap mass spectrometer is presented. We show that phosphotyrosine- and phosphothreo-
nine-containing peptides show complicated fragmentation patterns. These phosphopeptides
were observed to lose the phosphate moiety in the form of H3PO4 and/or HPO3, but were also
detected with no loss of the phosphate group. The tendency to lose the phosphate moiety
depends strongly on the charge state. Thus, the highest observed charge state tends to retain
the phosphate moiety with extensive fragmentation along the peptide backbone. We also show
that phosphoserine-containing peptides have relatively simple fragmentation patterns of
losing H3PO4. This loss is independent of the charge state. We suggest strategies for the
accurate identification of phosphorylation sites using the ion trap mass spectrometer. (J Am
Soc Mass Spectrom 1998, 9, 1175–1188) © 1998 American Society for Mass Spectrometry
Tandem mass spectrometry is becoming themethod of choice for the identification of phos-phorylation sites due to its reliability, sensitivity,
and speed [1–11]. Multiply charged phosphopeptide
ions generated by electrospray ionization (ESI) are
significantly easier to fragment than corresponding
singly charged ions, and the phosphate group is less
likely to be lost than from singly charged phosphopep-
tides generated by matrix-assisted laser desorption/
ionization (MALDI) under collision-induced-dissocia-
tion (CID) conditions [11, 12]. Using the triple-stage-
quadrupole (TSQ) mass spectrometer, and more
recently the quadrupole ion trap mass spectrometer, we
and others showed that fragmentation of phosphopep-
tides in tandem mass spectrometry is a general route for
determination of phosphorylation sites [9, 13]. In con-
trast, only limited success has been shown for the
decomposition of singly charged phosphopeptide ions
generated by MALDI with MALDI/time-of-flight
(TOF) instruments operated in postsource decay (PSD)
mode and in MALDI/ion trap instruments [8, 10, 11].
The ion trap mass spectrometer shows great promise
for the identification of phosphorylation site with high
sensitivity [13]. We recently developed a strategy that
uses phosphatase treatment with MALDI-TOF to iden-
tify phosphopeptides in a protein digest, followed by
ion trap mass spectrometry to identify the precise
phosphorylation sites [13]. This strategy allows the
identification of phosphorylation sites from phos-
phopeptides that cannot even be detected in the normal
(single-stage) mass spectrum. Ion trap mass spectrom-
eters are also unique in that the time scales for measur-
ing and exciting ions in tandem mass spectrometry
(MS/MS) mode are much longer than for nontrapping
mass spectrometers. This allows the observation of
decomposition channels that require less energy but
longer time and, because of this, it was observed that
phosphopeptides lose predominantly 98 Da (H3PO4)
when subjected to MS/MS in ion trap mass spectrom-
eters [14–16]. This mass loss often serves as a signature
for phosphopeptides.
In this paper, we report a study of fragmentation of
peptides containing phosphoserine, phosphothreonine,
and phosphotyrosine in an ion trap mass spectrometer.
We show that, in contrast to phosphoserine-containing
peptides, phosphothreonine- and phosphotyrosine-con-
taining peptides undergo complicated fragmentation
on losing the phosphate moiety, and the loss of the
phosphate moiety is charge state dependent.
Experimental
Materials and Sample Preparation
The expressed catalytic domain of myosin I heavy chain
kinase (MIHCK) of Acanthamoeba castellanii was purified
as described previously [17]. The phosphopeptide with
the sequence of RApSVVGTTYWMAPEVVK (pS denot-
ing phosphoserine) were generated with in-solution
digestion of MIHCK with sequencing grade modified
trypsin (Boehringer Mannheim, Indianapolis, IN) in 50
mM NH4HCO3 for 2 h at 37°C. Phosphopeptides with
the sequences of RASVVGTpTYWMAPEVVK, RASV-
VGpTTYWMAPEVVK, pSPQPLGGSHR, SPQPLGGp-
SHR, TNQGpYFFFHLPD-NH2, ERTMPRIPTLKNLED-
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LVTEpYHGNFSAW-NH2, GDAGSNpTINASY-NH2,
pyroERRIDTLNSDGpYTPEPARITSPD-NH2, and FAGV
EAGGARAPQPSSVVpYR were synthesized by the Tufts
University peptide sequencing core facility (Boston, MA).
The phosphopeptide IIESYEGNSpYTFIDPTQLPYNEK-
WEFPR was generated by in-gel digestion of the rat
colony stimulation factor-1 receptor (CSF-1R). The
phosphopeptide LFTGHPEpTLEK was obtained from
the 1998 mass spectrometry survey of the Association of
Biomolecular Resource Facilities (ABRF).
Electrospray/LC/Ion Trap and Nanospray Ion Trap
The electrospray liquid chromatography (LC) ion trap
(LCQ) system has been described previous [13]. A
second LCQ coupled with a nanospray ion source (The
Protein Analysis Company, Odense M, Denmark) was
also used to perform MSn (n 5 2,3) experiments. One
to 2 mL of the synthetic phosphopeptide samples dis-
solved in 50% methanol and 10% acetic acid were used
directly for nanospray. Samples requiring desalting
were done utilizing the technique described by Mann
[18]. Ions were isolated with a mass isolation window of
up to 4 Da for 12 charged ions, but this window was
reduced to 3 Da for ions of higher charge states. Spectra
were taken in profile mode in order to allow inspection
of peak shapes and accurate determination of isotopic
peak patterns when using nanospray. The automatic
gain control (AGC) was not used in experiments that
required better control of the ion population to maxi-
mize sensitivity. The collision energy parameter was
chosen to be the minimum needed to promote extensive
fragmentation while maximizing ion signal (usually
around 30% of the highest available collision energy as
defined in the LCQ control software for multiply
charged ions).
Results and Discussion
Phosphoserine loses H3PO4 through b-elimination to produce
dehydroalanine. Phosphoserine-containing peptides
were tested, and it was found that they all lose predom-
inantly a moiety with a mass of 98 Da in ion trap mass
spectrometry, in agreement with previous findings [13–
16]. For example, the peptide, RApSVVGTTYWMAPE-
VVK (monoisotopic mass 1972.98 Da), which is phos-
phorylated at the serine residue [14], shows one
transition m/z 987.5 to 938.7 (loss of 49 Da) (Figure 1a).
A high-resolution scan (Zoom Scan) confirms that the
ion of m/z 938.7 is doubly charged. Furthermore, most
of the b-type ions [19] are not observed; instead ions
with masses of bn 2 98 Da are found for the fragments







D ), showing their loss of H3PO4. Of course,
the y-type ions are observed because they do not
contain the phosphoserine (see y5 to y7, y9, and y12 to
y14 ions). Only one fragment ion, b12, resulting from
cleavages at the preferential residue of proline contains
the phosphate group.
Because we did not observe fragment ions generated
from cleavages on both sides of the phosphoserine,
positive identification of the product of phosphoserine
after losing the moiety of H3PO4 was not possible. To
investigate further the phosphorylation of this peptide,
we carried out a MS3 experiment by isolating and
fragmenting the product ions of m/z 938.7 (Figure 1b).
Now that the facile loss of the phosphate group has
occurred, we see extensive fragmentation along the
peptide backbone. A series of y ions are observed, of
which y15 at m/z 1648.8 and y14 at m/z 1579.5 (giving
a mass difference of 69.3 Da) unequivocally identify the
third residue as a dehydroalanine (69.1 Da).
The above experiment provides another route for
identifying phosphorylation sites. Locating phospho-
serine as a dehydroalanine becomes important when
the phosphate group is so unstable that it is lost in
preference to peptide-backbone cleavage, as was ob-
served in MALDI/ion trap experiments [11]. In an
electrospray ion trap mass spectrometer, we found that
loss of H3PO4 for multiply charged phosphopeptides
does not usually pose a serious problem for the identi-
fication of phosphorylation sites in MS2 experiments.
Although fragmentation along the peptide backbone
occurs, it can be much less facile than the loss of H3PO4.
Identification becomes difficult when two or more
serine/threonine/tyrosine residues are so closely
spaced that cleavage between them does not occur.
Loss of H3PO4 from phosphoserine does not depend on the
charge state. Because electrospray generates ions with
a distribution of charge states, we decided to examine
how the charge states influence the fragmentation of
phosphopeptides to choose the most appropriate one to
fragment. We found that ions of all available charge
states of phosphoserine-containing peptides lose H3PO4
and give some peptide backbone fragmentation. This is
illustrated for pSPQPLGGSHR (monoisotopic mass
1114.53 Da). The singly and doubly charged ions lose
H3PO4 and fragment along the peptide backbone (Fig-
ure 2a, b). Similarly, the triply charged ion (the highest
charge state) loses primarily H3PO4, but less peptide
backbone fragmentation occurs than with the singly
and doubly charged ions (Figure 2c). The three charge
states of a second peptide with the same sequence
except with phosphorylation at the second serine (SPQ-
PLGGpSHR) show dominant losses of H3PO4. Other
phosphoserine-containing peptides (data not shown)
confirmed that ions of different charge states also
fragment with similar 98-Da losses, suggesting that the
loss of H3PO4 from phosphoserine-containing peptides
is not charge state dependent.
For some phosphoserine-containing peptides, the
98-Da loss is not as dominant as that seen in Figures 1a
and 2. Nevertheless, these peptides did lose the H3PO4.
Two phosphopeptides of sequence SPQPLGGSHR,
where phosphorylation is at different serines, both
exhibit 98-Da loss. The peptide with phosphorylation at
the second serine, however, exhibits greater fragmenta-
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Figure 1. Phosphoserine loses predominantly H3PO4 through b elimination to produce dehydroala-
nine in tandem ion trap mass spectrometry. (a) MS2 spectrum of a doubly charged phosphopeptide
ion (m/z 987.5). A loss of 98 Da (H3PO4) is observed. The bn
D label denotes loss of 98 Da (i.e.,
bn-H3PO4). (b) MS
3 spectrum of the ion arising from loss of 98 Da [m/z 938.7 of the doubly charged
ion in (a)]. The y14 and y15 fragments have a mass difference of 69 Da that corresponds to the mass
of dehydroalanine, identifying the product of phosphoserine after losing 98 Da as dehydroalanine.
The “B” label denotes the dehydroalanine residue.
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Figure 2. Loss of H3PO4 is not charge state dependent for phosphoserine-containing peptides. (a)
MS2 spectrum of the singly charged ion (m/z 1115.5). (b) MS2 spectrum of the doubly charged ion
(m/z 558.3). (c) MS2 spectrum of the triply charged ion (m/z 372.5). Losses of H3PO4 (98 Da) are
observed in fragmentation of all charge states. Fragments with asterisk (e.g., y*n) represent loss of 17
Da (presumably NH3) from the corresponding bn or yn fragment.
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tion of the peptide backbone for all charge states.
Providing that another parameter exists that can influ-
ence fragmentation of phosphoserine-containing pep-
tides, the distance between the phosphoserine residue
and the residue that carries the charge (for example,
arginine at the C terminus) may be a factor in this
fragmentation, but this has not yet been evaluated.
Phosphotyrosine-containing peptides can lose H3PO4.
Phosphotyrosine-containing peptides cannot undergo
the same b-elimination reaction as phosphoserine- or
phosphothreonine-containing peptides. Phosphoty-
rosine-containing peptides, however, can lose a neutral
with the mass of 98 Da [16]. Our experiments, also in an
ion trap, with a wider range of phosphotyrosine-con-
taining peptides, showed similar results. For example,
the loss was observed in the product–ion spectrum of
the triply charged pyro-ERRIDTLNSDGpYTPEP-
ARITSPD-NH2 (monoisotopic mass 2664.26 Da, see
Figure 3). Zoom scans conclusively established that the
loss was indeed 98 Da. Strong losses of multiples of 18
Da (presumably of H2O) also occur. This loss was
usually not observed for the phosphoserine-containing
peptides, and it contrasts with the fragmentation of
phosphotyrosine-containing peptides induced by high-
energy collisions in a magnetic-sector instrument and
with low-energy CID in a triple-stage quadrupole in-
strument, where phosphotyrosine-containing peptides
often lose 80 Da [1, 3]. More backbone fragmentation
occurs for phosphotyrosine-containing peptides, often
making the identification of the tyrosine phosphoryla-
tion site easier than that of serine. In contrast to frag-
ments of phosphoserine-containing peptides, the frag-
ments containing the phosphotyrosine residue do not







12 in Figure 3).
Phosphotyrosine-containing peptides may lose HPO3. We
found one example of a phosphotyrosine-containing
peptide, FAGVEAGGARAPQPSSVVpYR (monoiso-
topic mass 2098.03 Da, Figure 4), that undergoes a loss
of 80 Da (HPO3), in agreement with what has been
observed in both magnetic-sector and triple-stage quad-
rupole instruments [1, 3]. This peptide also loses 98 Da,
and the backbone fragmentation is extensive. The frag-
ments containing the phosphotyrosine residue do not
subsequently lose the phosphate group (note all the y
ions).
Phosphotyrosine-containing peptides may not lose H3PO4 or
HPO3. We were surprised to observe that phosphoty-
rosine-containing peptides can fragment without loss of
the phosphate group as H3PO4 or HPO3. Instead, they
fragment only along the peptide backbone. Figure 5a
shows the product–ion spectrum of the 13 charged
peptide ions of IIESYEGNSpYTFIDPTQLPYNEK-
WEFPR (monoisotopic mass 3515.63 Da), and Figure 5b
shows the 11 charged peptide ions of GDAGSNpYI-
NASY-NH2 (monoisotopic mass 1309.52 Da). In neither
case did losses of 98 or 80 Da occur.
The origin of the 80- and 98-Da loss for phosphotyrosine-
containing peptides. The fragmentation pattern of the
peptide as shown in Figure 4 provides an illustrative
example for determining the origin of the 80- and 98-Da
losses by MS3. The ion corresponding to the 80-Da loss
(m/z 1010.0 as shown in Figure 4) was subjected to an
additional stage of fragmentation (MS3, see Figure 6a)
to give nearly exclusive fragmentation along the pep-
tide backbone. The b19 (m/z 1844.5) and b18 (m/z
1681.6) establish that the product formed by loss of 80
Da is tyrosine.
We observed the same 98-Da loss in a MALDI/ion
trap mass spectrometer from phosphotyrosine-contain-
ing peptides [11]. We hypothesized that this loss arises
from consecutive losses of HPO3 (80 Da) and H2O (18
Da), but this hypothesis was not tested [11]. Thus, we
carried out a MS3 experiment for the ion corresponding
to the 98-Da loss (m/z 1001.0 in Figure 4) and its second
generation product–ion spectrum is shown in Figure 6b.
Surprisingly, two ions labeled b19
$ (m/z 1844.8), b18
(m/z 1681.7) were observed, identifying the product
structure at the phosphotyrosine site as tyrosine. An-
other molecule of H2O must be lost in the peptide to
account for this mass difference of 18 Da. The mass of
the b19
$ ion also locates the position of the H2O loss at
the arginine residue and the C terminus. The compli-
mentary y2
D fragment (m/z 320.1, corresponding to the
arginine and tyrosine minus H2O) further confirmed
this identification. The H2O loss is not from the two
serine residues even though peptides containing serine
tend to lose H2O, but instead from the arginine or more
likely the C terminus. We could not distinguish the loss
of 98 Da as a one-step loss of H3PO4 (analogous to b-
elimination of phosphoserine-containing peptides) or a
two-step loss of the HPO3 group, followed by loss of the
H2O, as commonly occurring in CID of peptide ions.
The above observation, however, is evidence against
the two-step loss mechanism as dominant for the 98-Da
loss, because loss of H2O from the C terminus is not
often observed under normal circumstances. A more
likely mechanism for the net 98-Da loss is that H3PO4 is
lost in one step through a rearrangement reaction. The
long timescale of the ion trap mass spectrometer allows
this type of rearrangement reaction to occur.
Loss of the phosphate from phosphotyrosine is charge state
dependent. We were puzzled by the observation that
phosphotyrosine-containing peptides sometimes do not
lose the phosphate group at all. A study of phosphoty-
rosine-containing peptides with different charge states
revealed that ions of the highest charge state do not
produce a loss of either 98 or 80 Da. The product–ion
spectra of a phosphopeptide of ERTMPRIPTLKNLED-
LVTEpYHGNFSAW-NH2 (monoisotopic mass 3295.60
Da) with the 12, 13 and 14 charge states are shown in
Figure 7. The 12 and 13 charge states showed 98-Da
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Figure 3. Phosphotyrosine-containing peptides may formally lose H3PO4 in tandem ion trap mass
spectrometry. The MS/MS spectrum of a triply charged phosphotyrosine-containing peptide ion (m/z
889.1) of pyro-ERRIDTLNSDGpYTPEPARITSPD-NH2. The C terminus is an amide. A loss of 98 Da is
observed (see the peak corresponding to the ion at m/z 856.7).
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losses as expected (Figure 7a, b), whereas the 14 charge
state (highest observed charge state) did not undergo
this loss (Figure 7c). Rather, fragmentation occurs along
the peptide backbone and resulted in a fragmentation
pattern characteristic of unphosphorylated peptides.
Similar results were also found for a range of phospho-
tyrosine-containing peptides (Table 1). The highest
charge states of these peptides were either experimen-
Figure 4. Phosphotyrosine-containing peptides may formally lose HPO3. MS
2 spectrum of a doubly
charged phosphotyrosine-containing peptide ion (m/z 1050.0). Losses of both H3PO4 and HPO3 are
observed. Note that fragment ions containing phosphotyrosine do not lose an additional H3PO4
moiety.
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Figure 5. Phosphotyrosine-containing peptides may not lose the phosphate group. (a) LC/MS/MS
spectrum of a triply charged phosphotyrosine-containing peptide ion (m/z 1172.9) of sequence
IIESYEGNSpYTFIDPTQLPYNEKWEFPR. No observable loss of either H3PO4 (98 Da) or HPO3 (80 Da)
is apparent. (b) MS2 spectrum of a singly charged phosphotyrosine-containing peptide ion (m/z
1310.5) of GDAGSNpYINASY-NH2 by nanospray. The C terminus is an amide. Loss of water and
some peptide backbone fragmentation are observed but no loss of H3PO4 (98 Da) or HPO3 (80 Da) is
observed.
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Figure 6. The origin of the 80- and 98-Da loss for phosphotyrosine containing peptides. (a) MS3
spectrum of the ion (m/z 1010.0 in Figure 4) corresponding to the loss of HPO3 from the doubly
charged precursor ion (m/z 1050.0). The observed b19 and b18 ions identify the phosphotyrosine
residue after losing 80 Da as tyrosine. (b) MS3 spectrum of the ion (m/z 1001.0) corresponding to the
loss of H3PO4 from the doubly charged precursor ion (m/z 1050.0 in Figure 4). The observed b19 and
b18 identify the phosphotyrosine residue after losing 98 Da as tyrosine. The H2O loss that accounts for
the additional 18-Da loss must occur at the R residue or the C terminus. The y2
D ion confirms this
conclusion.
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Figure 7. Loss of the phosphate moiety depends strongly on the charge state of phosphotyrosine-
containing peptides. (a) MS2 spectrum of the doubly charged ion (m/z 1648.8). A loss of H3PO4 is
observed. (b) MS2 spectrum of the triply charged ion (m/z 1099.5). A loss of H3PO4 is observed. (c)
MS2 spectra of the quadruply charged ion (m/z 824.9). A loss of H3PO4 or HPO3 is not observed.
Unlike phosphoserine-containing peptides, loss of the phosphate is charge state dependent. The C
terminus is an amide.
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tally observed or estimated from the number of charge-
able amino acid residues (arginine, lysine, histidine,
and N terminus). There might exist one charge differ-
ence between the observed highest charge state and the
calculated one.
These results suggest that a competing fragmenta-
tion pathway exists, that it is charge-state dependent,
and it somehow prevents elimination of the phosphate
group. This observation is surprising, as the phosphate
P–O bond is much weaker than the peptide bond. We
hypothesize that the charged amino-acid residues inter-
act with the phosphate group to stabilize it (perhaps in
the form of a salt bridge [20]), resulting in a different
chemical structure from the neutral peptide and the
peptide ions of lower charge states. The long timescale
in the ion trap may facilitate this process. As for
phosphoserine-containing peptides, the phosphate is so
unstable that the interaction with the charged group is
insufficient to stabilize it.
Phosphothreonine loses H3PO4 through b-elimination and
HPO3 through dephosphorylation. Others have noted
that fragmentation loss of H3PO4 from phosphothreo-
nine-containing peptides is similar to that of phospho-
serine-containing peptides [15]. Prompted by our obser-
vation of the diverse and complicated fragmentation
patterns for phosphotyrosine-containing peptides, we
performed a detailed investigation of phosphothreo-
nine-containing peptides. Similar to phosphoserine-
containing peptides, the 12 ion of RASVVGTpTYW-
MAPEVVK (monoisotopic mass 1972.98 Da) fragments
with an appreciable loss of 98 Da (H3PO4), in agreement
with previous findings (note the m/z 939 ion in Figure
8a). To our surprise, a careful inspection of the spec-
trum revealed an ion of m/z 947.5, which may form by
loss of 80 Da (HPO3). Some fragments containing the
phosphothreonine residue lose the H3PO4 group (see
the labeled bn and bn
D ions), placing the stability of the
phosphothreonine residue between those of phospho-
serine and phosphotyrosine.
To verify that the product formed by loss of 98 Da is
the dehydroaminobutyric acid (a b-elimination), the
ions formed by loss of H3PO4 were isolated and sub-
jected to MS3 (Figure 8b). The observed b8 and b7 ions of
m/z 754.3 and 671.3 confirmed the product as the
dehydroaminobutyric acid. This conclusion was further
confirmed by the complimentary y ion series (see y10
and y9 ions).
To examine further the product from the unexpected
80-Da loss, we isolated the ions from loss of HPO3 and
subjected them to MS3 (Figure 8c). The mass difference
(100.9 Da) between b8 and b7 ions identifies the residue
as threonine, a product of dephosphorylation. Appar-
ently, two competing channels operate, leading to the
loss of H3PO4 and HPO3. The same peptide when
phosphorylated at the serine residue does not show any
loss of 80 Da in MS2 (see Figure 1a).
Loss of the phosphate from phosphothreonine is charge state
dependent. Similar to phosphotyrosine-containing pep-
tides, loss of the phosphate group for phosphothreonine
containing peptides also depends on the charge state.
The ions of the highest charge do not lose the phosphate
group (see Table 1). Figure 9 shows the product–ion
spectra of the peptide LFTGHPEpTLEK (monoisotopic
mass 1350.66 Da) for the 12 (Figure 9a) and 13 (Figure
9b) states. Loss of 98 Da is observed for 12 but not for
13 (the highest observed charge state). This is similar to
the fragmentation loss of 98 Da from phosphotyrosine-
containing peptides.
Implications for the identification of phosphorylation sites.
The evidence presented in this investigation suggests
that the loss of 98 Da can always be used as a signature
for phosphopeptides in an ion trap, however, the op-
posite is not always true. The lack of 98-Da loss from the
highest charge state of phosphotyrosine or phospho-
threonine-containing peptides cannot be used as evi-
dence to assign them as unphosphorylated peptides. In
addition, phosphorylation on serine, tyrosine, and thre-
onine cannot generally be distinguished from each
other based solely on an observed loss of H3PO4 (98 Da)
from all charge states in tandem ion trap mass spec-
trometry. Is evidence available elsewhere in the spec-
trum? It may be possible to distinguish phosphoserine
from the other two phosphoamino acids by the ob-
served 98-Da loss if the highest observed charge state is
fragmented. Loss of 98 Da from the highest charge state
suggests the presence of a phosphoserine-containing
peptide. Peptides containing these three phosphoamino
acids may also be distinguished by their fragment ions
that contain the phosphoamino acid. Phosphoserine-
Table 1. Summary of fragmentation of phosphotyrosine- and phosphothreonine-containing peptides









aNone indicates no loss of H3PO4 from the maximum charge state but loss of H3PO4 from all lower-charge states.
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Figure 8. Phosphothreonine-containing peptides may lose H3PO4 through b elimination and HPO3
through dephosphorylation. (a) MS2 spectrum of the doubly charged phosphopeptide ion (m/z 987.6).
Losses of both H3PO4 and HPO3 are observed. Fragment ions containing phosphothreonine partially
lose H3PO4. (b) MS
2 spectrum of the ion (m/z 939.0) corresponding to the loss of H3PO4 from the
doubly charged precursor ion [m/z 987.6 of (a)]. The observed b8 and b7 identify the product of
phosphothreonine after losing 98 Da as dehydroaminobutyric acid. The complimentary y10 and y9
ions confirm this conclusion. (c) MS3 spectrum of the ion [m/z 947.5 in (a)] corresponding to the loss
of HPO3 from the doubly charged precursor ion (m/z 987.6). The observed b8 and b7 identify the
product of phosphothreonine after losing 80 Da as threonine.
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Figure 9. Loss of the phosphate moiety also depends on the charge state of phosphothreonine-
containing peptides. (a) MS2 spectrum of the doubly charged phosphothreonine-containing peptide
ion (m/z 676.3). A dominant loss of H3PO4 is observed along with some peptide backbone
fragmentation. The yn
D label denotes loss of H3PO4 (i.e., yn-H3PO4). (b) MS
2 spectra of the triply
charged phosphothreonine-containing peptide ion (m/z 451.2). The 13 charge state is the highest
charge state and shows no loss of 98 or 80 Da. Loss of 98 Da appears only for a few fragment ions. Like
phosphotyrosine-containing peptides, loss of H3PO4 is charge state dependent.
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containing fragments tend to lose H3PO4 completely,
but phosphotyrosine-containing fragments do not lose
H3PO4. Some phosphothreonine-containing fragments
partially lose H3PO4, showing intermediate behavior. In
any case, only through direct sequencing can the phos-
phorylation site be unambiguously determined.
What strategy is best to sequence phosphopeptides
for the identification of phosphorylation sites? The
results suggest that for phosphothreonine and phos-
photyrosine-containing peptides, ions of the highest
charge state might be a better choice for determining the
phosphorylation site, as the highest charge states often
produce more intensive fragmentation along the pep-
tide backbone (see Figure 7a, b, and c). For phospho-
serine-containing peptides, the charge state with the
most intense peak should be chosen.
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